Table 4

Fisher's exact test between RXRs cytoplasmic expression and different clinicopathological data of the patients presenting infiltrative carcinomas.


RXR-α C
 RXR-β C
 RXR-γ C




Negative
 Weak
 High
 p-value
 Negative
 Weak
 High
 p-value
 Negative
 Weak
 High
 p-value
Tumor Type
 Ductal
 30
 3
 21
 0.264
 24
 12
 18
 0.838
 19
 10
 25
 0.151

Lobular
 14
 3
 5
10
 6
 6
13
 2
 7














Age
 <50
 12
 3
 4
 0.185
 10
 4
 5
 0.765
 5
 3
 11
 0.254

>50
 33
 3
 22
25
 14
 19
27
 9
 22














Tumor size
 1
 15
 4
 12
 0.697
 12
 11
 8
 0.292
 15
 7
 9
 0.392

2
 22
 2
 9
17
 4
 12
12
 5
 16

3
 3
 0
 2
1
 2
 2
2
 0
 3

4
 5
 0
 3
5
 1
 2
3
 0
 5














Nodal status
 -
 22
 3
 10
 0.678
 17
 12
 6
 0.024
 18
 9
 8
 0.003

+
 23
 3
 16
18
 6
 18
14
 3
 25














ER
 0
 10
 0
 7
 0.274
 6
 2
 9
 0.060
 2
 3
 12
 0.000

1
 6
 0
 0
3
 0
 3
1
 0
 5

2
 6
 2
 4
4
 6
 2
2
 4
 6

3
 23
 4
 15
22
 10
 10
27
 5
 10














PR
 0
 13
 1
 7
 0.296
 11
 5
 5
 0.480
 9
 2
 10
 0.009

1
 7
 0
 0
3
 0
 4
0
 0
 7

2
 8
 1
 4
5
 5
 3
4
 5
 4

3
 17
 4
 15
16
 8
 12
19
 5
 12

Tumor size (TNM): T = 1, 2, 3, 4. ER and PR: 0 = Negative, 1 = Weak immunoreaction, 2/3 = High immunoreaction. C: Cytoplasmic immunoreaction.

Conde et al. BMC Cancer 2008 8:174   doi:10.1186/1471-2407-8-174